期刊文献+

神经外科重症监护病房导管相关性感染病原菌分布与耐药性分析 被引量:8

Distribution and antimicrobial resistance of venous catheter-related infections in a neurosurgical intensive care unit
原文传递
导出
摘要 目的探讨神经外科重症监护病房导管相关性感染病原菌分布及其对常用抗菌药物的耐药情况。方法对2008年1月~2010年12月送检的169例导管标本进行分离培养,并对分离出的病原菌进行抗菌药物敏感性检测。结果共检出导管相关性感染病原菌62株,其中革兰阳性球菌38株,革兰阴性杆菌24株,以表皮葡萄球菌(15株,24.19%)、鲍曼不动杆菌(9株,14.52%)、金黄色葡萄球菌(8株,12.90%)、溶血葡萄球菌(6株,9.68%)和肺炎克雷伯菌(6株,9.68%)为主要病原菌;药敏结果示革兰阳性菌对万古霉素较为敏感,而革兰阴性菌对亚胺培南敏感性较高。结论神经外科重症监护病房导管相关性感染以革兰阳性球菌为主,并呈现多重耐药性。 Objective To investigate the distribution of pathogens responsible for venous catheter-related infections in a neurosurgical intensive care unit(NICU) and their drug resistance.Methods The pathogens from 169 catheter specimens collected from January 2008 to December 2010 were isolated and cultured and the drug sensitivity testing of the isolated pathogens was performed.Results In total,62 strains of bacteria responsible for venous catheter-related infection were identified;of these,38 strains were Gram-positive cocci while 24 were Gram-negative bacilli.Staphylococcus epidermidis(24.19%),Acinetobacter baumannii(14.52%),Staphylococcus aureus(12.90%),Staphylococcus hemolyticus(9.68%),and Klebsiella pneumonia(9.68%) were the pathogens isolated most often.The results of drug sensitivity testing showed that Gram-positive bacterial isolates were sensitive to vancomycin while Gram-negative bacteria were sensitive to imipenem.Conclusion Gram-positive cocci were the pathogens predominantly responsible for venous catheter-related infections in a NICU,and these pathogens have multidrug resistance.
作者 苏敏 徐鹏
出处 《中国病原生物学杂志》 CSCD 北大核心 2012年第1期63-65,共3页 Journal of Pathogen Biology
关键词 导管相关性感染 病原菌 耐药性 Venous catheter-related infections pathogen drug resistance
  • 相关文献

参考文献10

二级参考文献59

共引文献107

同被引文献97

  • 1张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:90
  • 2张婴元,张敬德,周乐,吴培澄,陈友娣,王宇倩,汪复.头孢哌酮-舒巴坦体外抗菌作用研究[J].中华内科杂志,1995,34(10):676-679. 被引量:52
  • 3朱旭慧,孙自镛,简翠,李丽,张蓓,申正义.不动杆菌属的耐药性分析[J].中国抗感染化疗杂志,2005,5(6):342-345. 被引量:37
  • 4Simor AE, Lee M, Vearncomber M, et al. An outbreak due to multiresistant Acinetobacterbaumannll in a burn unit: risk factors for acquisition and management [J]. Infect Control Hosp Epide- miol, 2002, 23: 261--7.
  • 5Rogues AM, Dumartin C, Amdeo B, et al. Relationship between rates of antimierobial consumpt ion and the incidence of antimicro- bial resistance in Staphylococcus aureus and Pseudomonas aerugi- nosa isolates from 47 French hospital[J]. Infect Control Hosp Epi- demiol, 2007, 28: 1389--95.
  • 6Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. From Chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11) : 4022- 8.
  • 7Zavascki AP, Goldani LZ, Li J, et al. Polymyxin B for the treatment of multidrug-resistant pathogens~a critical review[J]. J Antimierob Chemother, 2008, 60(6):1206--15.
  • 8Suh B, Shapiro T, Jones R, et al. In vitro activity of B lactamase against clinical isolates of acinetobacter species[J]. Microb lnfect Dis,1995,21 (2):111--41.
  • 9Levin AS, Levy CE, Manrique AE, et al. Severe nosocomial in-fection with imipenem- resistance Acinetobacter baumannii treated with ampieilin/ sulbaetam [J]. Int J Antimieroh Agents, 2003,21 (1) : 58--62.
  • 10Levin AS, Barone AA, Penco J, et al. Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistance Pseudomonas aeruginosa and Acinetobacter baumannii [J]. Clin Infect Dis,1999, 28(5): 1008--11.

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部